[Journal logo]

Volume 64 
Part 7 
Pages m853-m854  
July 2008  

Received 24 May 2008
Accepted 26 May 2008
Online 7 June 2008

Key indicators
Single-crystal X-ray study
T = 100 K
Mean [sigma](C-C) = 0.002 Å
R = 0.042
wR = 0.104
Data-to-parameter ratio = 41.3
Details
Open access

Tetrakis(4-aminopyridine-[kappa]N1)dichloridocopper(II) monohydrate

aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia,bDepartment of Electronics, St Joseph's College, Tiruchirappalli 620 001, India, and cDepartment of Physics, Karunya University, Karunya Nagar, Coimbatore 641 114, India
Correspondence e-mail: hkfun@usm.my

The asymmetric unit of the title compound, [CuCl2(C5H6N2)4]·H2O, contains two crystallographically independent complex molecules and two water molecules. The CuII ion in each molecule is six-coordinated in an elongated octahedral geometry, with the equatorial plane defined by four pyridine N atoms of four aminopyridine ligands and the axial positions occupied by two Cl atoms. In the crystal structure, molecules are linked into a three-dimensional framework by C-H...Cl, O-H...Cl, N-H...O, N-H...Cl and N-H...N hydrogen bonds and C/N-H...[pi] interactions involving the pyridine rings.

Related literature

For related literature on 4-aminopyridine, see: Judge & Bever (2006[Judge, S. & Bever, C. (2006). Pharmacol. Ther. 111, 224-259.]); Schwid et al. (1997[Schwid, S. B., Petrie, M. D., McDermott, M. P., Tierney, D. S., Mason, D. H. & Goodman, A. D. (1997). Neurology, 48, 817-821.]); Strupp et al. (2004[Strupp, M., Kalla, R., Dichgans, M., Fraitinger, T., Glasauer, S. & Brandt, T. (2004). Neurology, 62, 1623-1625.]). For bond lengths, see: Moncol et al. (2004[Moncol, J., Mudra, M., Lonnecke, P., Koman, M. & Melink, M. (2004). J. Chem. Crystallogr. 34, 423-431.]); Zaleski et al. (2005[Zaleski, J., Gabryszewski, M. & Zarychta, B. (2005). Acta Cryst. C61, m151-m154.]); Anderson et al. (2005[Anderson, F. P., Gallagher, J. F., Kenny, P. T. M. & Lough, A. J. (2005). Acta Cryst. E61, o1350-o1353.]).

[Scheme 1]

Experimental

Crystal data
  • [CuCl2(C5H6N2)4]·H2O

  • Mr = 528.93

  • Triclinic, [P \overline 1]

  • a = 9.5430 (2) Å

  • b = 14.1606 (2) Å

  • c = 17.4662 (3) Å

  • [alpha] = 88.463 (1)°

  • [beta] = 86.075 (1)°

  • [gamma] = 85.781 (1)°

  • V = 2347.81 (7) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 1.19 mm-1

  • T = 100.0 (1) K

  • 0.51 × 0.40 × 0.12 mm

Data collection
  • Bruker SMART APEXII CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.583, Tmax = 0.871

  • 106511 measured reflections

  • 24484 independent reflections

  • 17417 reflections with I > 2[sigma](I)

  • Rint = 0.047

Refinement
  • R[F2 > 2[sigma](F2)] = 0.041

  • wR(F2) = 0.104

  • S = 1.07

  • 24484 reflections

  • 593 parameters

  • 6 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.92 e Å-3

  • [Delta][rho]min = -1.11 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

Cg1, Cg2 and Cg3 are centroids of the N1/C1-C5, N9/C21-C25 and N11/C26-C30 rings, respectively.

D-H...A D-H H...A D...A D-H...A
C2-H2...Cl2i 0.93 2.68 3.5955 (13) 167
C6-H6...Cl2 0.93 2.80 3.3665 (13) 121
C10-H10...Cl1 0.93 2.78 3.4430 (13) 129
C20-H20...Cl1 0.93 2.64 3.3522 (13) 134
C25-H25...Cl4 0.93 2.71 3.2928 (13) 121
C26-H26...N9 0.93 2.62 3.0473 (17) 108
C35-H35...Cl4 0.93 2.67 3.3947 (14) 136
N4-H4A...O1Wii 0.86 2.38 3.2094 (17) 163
N4-H4B...Cl1iii 0.86 2.43 3.2893 (13) 175
N6-H6A...Cl4iv 0.86 2.82 3.4066 (13) 127
N8-H8B...Cl2iv 0.86 2.56 3.4021 (13) 166
N10-H10B...Cl3v 0.86 2.41 3.2596 (11) 171
N12-H12A...O1W 0.86 2.06 2.8908 (16) 162
N14-H14B...O1Wvi 0.86 2.25 3.0103 (18) 147
N16-H16B...N16vii 0.86 2.52 3.2036 (17) 137
O1W-H1W1...Cl1iii 0.83 (1) 2.26 (1) 3.0614 (12) 163 (2)
O1W-H2W1...Cl4viii 0.83 (1) 2.26 (1) 3.0694 (12) 164 (2)
C37-H37...Cg1ix 0.93 2.81 3.5492 (14) 137
C39-H39...Cg1x 0.93 2.95 3.7306 (14) 142
N2-H2B...Cg2xi 0.86 2.75 3.3359 (13) 126
C12-H12...Cg3 0.93 2.79 3.6488 (14) 154
C14-H14...Cg3iv 0.93 2.83 3.6193 (13) 144
Symmetry codes: (i) -x+1, -y, -z; (ii) -x+2, -y, -z+1; (iii) -x+1, -y, -z+1; (iv) x-1, y, z; (v) -x+2, -y+1, -z; (vi) -x+1, -y+1, -z+1; (vii) -x+2, -y+2, -z; (viii) -x+2, -y+1, -z+1; (ix) x, y+1, z; (x) x+1, y+1, z; (xi) x-1, y-1, z.

Data collection: APEX2 (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: APEX2; data reduction: SAINT (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); program(s) used to solve structure: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2003[Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CI2603 ).


Acknowledgements

HKF and SRJ thank the Malaysian Government and Universiti Sains Malaysia for Science Fund Grant No. 305/PFIZIK/613312. SRJ thanks the Universiti Sains Malaysia for a post-doctoral research fellowship.

References

Anderson, F. P., Gallagher, J. F., Kenny, P. T. M. & Lough, A. J. (2005). Acta Cryst. E61, o1350-o1353.  [CrossRef] [details]
Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Judge, S. & Bever, C. (2006). Pharmacol. Ther. 111, 224-259.  [CrossRef] [PubMed] [ChemPort]
Moncol, J., Mudra, M., Lonnecke, P., Koman, M. & Melink, M. (2004). J. Chem. Crystallogr. 34, 423-431.  [CrossRef] [ChemPort]
Schwid, S. B., Petrie, M. D., McDermott, M. P., Tierney, D. S., Mason, D. H. & Goodman, A. D. (1997). Neurology, 48, 817-821.  [ChemPort] [PubMed] [ISI]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.  [CrossRef] [details]
Strupp, M., Kalla, R., Dichgans, M., Fraitinger, T., Glasauer, S. & Brandt, T. (2004). Neurology, 62, 1623-1625.  [ISI] [PubMed] [ChemPort]
Zaleski, J., Gabryszewski, M. & Zarychta, B. (2005). Acta Cryst. C61, m151-m154.  [CrossRef] [details]


Acta Cryst (2008). E64, m853-m854   [ doi:10.1107/S1600536808015778 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.